Name: ABSA’s 1st Biosecurity Symposium
Start: 2021-04-20T00:00:00-05:00
End: 2021-04-23T23:59:59-05:00
Location: Renaissance Depot Hotel

CDC Updates Monkeypox Travel Alert for Nigeria

USAMRIID Study Leads to Approval of New Smallpox Vaccine
Why Do We Need a New Smallpox Vaccine?
FDA Approves Jynneos to Prevent Smallpox and Monkeypox

Monkeypox in Nigeria: The Value of Local Surveillance and Genetic Sequencing

by Global Biodefense Staff February 19, 2018, 1:15 am
WHO Updates Blueprint List of Priority Diseases

by Global Biodefense Staff February 12, 2018, 5:51 pm

Monkeypox

CDC Updates Monkeypox Travel Alert for Nigeria

USAMRIID Study Leads to Approval of New Smallpox Vaccine

Why Do We Need a New Smallpox Vaccine?

FDA Approves Jynneos to Prevent Smallpox and Monkeypox

Monkeypox in Nigeria: The Value of Local Surveillance and Genetic Sequencing

WHO Updates Blueprint List of Priority Diseases

Biodefense Headlines – 21 January 2021

First Cases of B.1.1.7 Variant COVID-19 Detected in Washington State

The Response Measures Database: Central Archive of COVID-19 Interventions

EU Initiative on Health Security Work Programme 2021

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

Dr. Fauci Makes First Appearance at Biden White House Press Briefing – Transcript

ASM Expresses Support for the Global Health Security Act of 2021

How and When Will Lower-Income Countries Gain Access to COVID-19 Vaccines?

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

Emerging Infections Network – Managing Travelers Who Acquire Disease Abroad

Upcoming Events

Application Deadline: Expanding Existing Research Grants, CRADAs for Novel Coronavirus Response

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 2

Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 3

ABSA’s 1st Biosecurity Symposium

Latest stories

Latest Articles